Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pakistan Pharmas Call For 20 Percent Increase In Allowed Drug Prices

This article was originally published in PharmAsia News

Executive Summary

The Pakistan Pharmaceutical Manufacturers Association is calling for a 20 percent increase in the allowed prices for drugs in the country. The industry cites added costs of raw materials and energy as well as the devalued Pakistani currency as reasons for allowing a price hike. The group said lifting the cap on drug prices was essential if the nation's drug-making industry is to survive. The PPMA estimated lifting the caps would save Pakistan the $3 billion cost of importing foreign-made drugs that comprise more than 90 percent of drugs available in the country. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts